Zyla Life Sciences Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Zyla Life Sciences reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$20.61 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-05-10
- Zyla Life Sciences net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$20.61M.
- Zyla Life Sciences net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was -$15.79M.
- Zyla Life Sciences net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was -$21.12M.
- Zyla Life Sciences net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-06-30 was -$17.16M.
- Zyla Life Sciences net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$72.87M.
- Zyla Life Sciences net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$38.91M.
- Zyla Life Sciences net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$25.07M.
- Zyla Life Sciences net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$433.00K.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$20.61M 10-Q · filed 2017-05-10 | -$36.40M derived: sum of 2 quarters · filed 2017-05-10 | -$57.52M derived: sum of 3 quarters · filed 2017-05-10 | -$74.68M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | -$15.79M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$36.91M derived: sum of 2 quarters · filed 2017-03-13 | -$54.07M derived: sum of 3 quarters · filed 2017-03-13 | -$72.87M 10-K · filed 2017-03-13 |
| 2016-09-30 | -$21.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$38.28M derived: sum of 2 quarters · filed 2016-11-08 | -$57.08M 10-Q · filed 2016-11-08 | -$75.23M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-06-30 | -$17.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$35.96M 10-Q · filed 2016-08-05 | -$54.11M derived: sum of 3 quarters · filed 2017-05-10 | -$72.80M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-03-31 | -$18.79M 10-Q · filed 2017-05-10 | -$36.95M derived: sum of 2 quarters · filed 2017-05-10 | -$55.64M derived: sum of 3 quarters · filed 2017-05-10 | -$57.86M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | -$18.16M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$36.84M derived: sum of 2 quarters · filed 2017-03-13 | -$39.07M derived: sum of 3 quarters · filed 2017-03-13 | -$38.91M 10-K · filed 2017-03-13 |
| 2015-09-30 | -$18.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$20.91M derived: sum of 2 quarters · filed 2016-11-08 | -$20.75M 10-Q · filed 2016-11-08 | -$26.85M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | -$2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$2.06M 10-Q · filed 2016-08-05 | -$8.16M derived: sum of 3 quarters · filed 2017-03-13 | -$16.30M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $163.00K 10-Q · filed 2016-05-10 | -$5.94M derived: sum of 2 quarters · filed 2017-03-13 | -$14.07M derived: sum of 3 quarters · filed 2017-03-13 | -$19.83M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | -$6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$14.24M derived: sum of 2 quarters · filed 2017-03-13 | -$19.99M derived: sum of 3 quarters · filed 2017-03-13 | -$25.07M 10-K · filed 2017-03-13 |
| 2014-09-30 | -$8.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$13.89M derived: sum of 2 quarters · filed 2015-11-06 | -$18.97M 10-Q · filed 2015-11-06 | -$11.93M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | -$5.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$10.84M 10-Q · filed 2015-08-07 | -$3.80M derived: sum of 3 quarters · filed 2016-03-11 | -$6.08M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | -$5.08M 10-Q · filed 2015-05-08 | $1.96M derived: sum of 2 quarters · filed 2016-03-11 | -$329.00K derived: sum of 3 quarters · filed 2016-03-11 | -$2.98M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $7.04M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $4.75M derived: sum of 2 quarters · filed 2016-03-11 | $2.10M derived: sum of 3 quarters · filed 2016-03-11 | -$433.00K 10-K · filed 2016-03-11 |
| 2013-09-30 | -$2.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$4.94M derived: sum of 2 quarters · filed 2014-11-14 | -$7.47M 10-Q · filed 2014-11-14 | |
| 2013-06-30 | -$2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$5.18M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$2.54M 10-Q · filed 2014-06-11 | |||
| 2012-12-31 | -$5.46M 10-K · filed 2015-03-16 |